array:21 [
  "pii" => "X201325141105158X"
  "issn" => "20132514"
  "doi" => "10.3265/Nefrologia.pre2010.Nov.10729"
  "estado" => "S300"
  "fechaPublicacion" => "2011-03-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia (English Version). 2011;31:221-2"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 4361
    "formatos" => array:3 [
      "EPUB" => 318
      "HTML" => 3498
      "PDF" => 545
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:17 [
      "pii" => "X0211699511051582"
      "issn" => "02116995"
      "doi" => "10.3265/Nefrologia.pre2010.Nov.10729"
      "estado" => "S300"
      "fechaPublicacion" => "2011-03-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2011;31:221-2"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 7071
        "formatos" => array:3 [
          "EPUB" => 318
          "HTML" => 6109
          "PDF" => 644
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "titulo" => "Nefropatía tras la administración de inhibidores de la angiogénesis"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "221"
            "paginaFinal" => "222"
          ]
        ]
        "contieneResumen" => array:1 [
          "es" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "ARANTXA VELLO ROMÁN, A. Vello Román, MIRIAM SAMPRÓN RODRÍGUEZ, M. Samprón Rodríguez, BEATRIZ PAZOS ARIAS, B. Pazos Arias, CARLOS ROMERO REINOSO, C. Romero Reinoso, ANGELES PETEIRO CANCELO, A. Peteiro Cancelo"
            "autores" => array:10 [
              0 => array:2 [
                "nombre" => "ARANTXA"
                "apellidos" => "VELLO ROMÁN"
              ]
              1 => array:2 [
                "Iniciales" => "A."
                "apellidos" => "Vello Román"
              ]
              2 => array:2 [
                "nombre" => "MIRIAM"
                "apellidos" => "SAMPRÓN RODRÍGUEZ"
              ]
              3 => array:2 [
                "Iniciales" => "M."
                "apellidos" => "Samprón Rodríguez"
              ]
              4 => array:2 [
                "nombre" => "BEATRIZ"
                "apellidos" => "PAZOS ARIAS"
              ]
              5 => array:2 [
                "Iniciales" => "B."
                "apellidos" => "Pazos Arias"
              ]
              6 => array:2 [
                "nombre" => "CARLOS"
                "apellidos" => "ROMERO REINOSO"
              ]
              7 => array:2 [
                "Iniciales" => "C."
                "apellidos" => "Romero Reinoso"
              ]
              8 => array:2 [
                "nombre" => "ANGELES"
                "apellidos" => "PETEIRO CANCELO"
              ]
              9 => array:2 [
                "Iniciales" => "A."
                "apellidos" => "Peteiro Cancelo"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "X201325141105158X"
          "doi" => "10.3265/Nefrologia.pre2010.Nov.10729"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325141105158X?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511051582?idApp=UINPBA000064"
      "url" => "/02116995/0000003100000002/v0_201502091417/X0211699511051582/v0_201502091417/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251411051571"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.pre2010.Nov.10508"
    "estado" => "S300"
    "fechaPublicacion" => "2011-03-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2011;31:223-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 8435
      "formatos" => array:3 [
        "EPUB" => 314
        "HTML" => 7465
        "PDF" => 656
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "First case of peritoneal infection due to Oerskovia turbata (Cellulosimicrobium funkei)"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "223"
          "paginaFinal" => "225"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Primer caso de infección peritoneal por Oerskovia turbata (Cellulosimicrobium funkei)"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Fig. 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier España"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "10508_108_15826_en_10508_1.jpg"
              "Alto" => 399
              "Ancho" => 600
              "Tamanyo" => 191528
            ]
          ]
          "descripcion" => array:1 [
            "en" => "Oerskovia culture on a blood agar plate"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L. BETANCOURT CASTELLANOS, E. PONZ CLEMENTE, D. FONTANALS AYMERICH, C. BLASCO CABAÑAS, D. MARQUINA PARRA, C. GRAU PUEYO, M. GARCÍA GARCÍA"
          "autores" => array:8 [
            0 => array:2 [
              "Iniciales" => "L."
              "apellidos" => "BETANCOURT CASTELLANOS"
            ]
            1 => array:2 [
              "Iniciales" => "L."
              "apellidos" => "BETANCOURT CASTELLANOS"
            ]
            2 => array:2 [
              "Iniciales" => "E."
              "apellidos" => "PONZ CLEMENTE"
            ]
            3 => array:2 [
              "Iniciales" => "D."
              "apellidos" => "FONTANALS AYMERICH"
            ]
            4 => array:2 [
              "Iniciales" => "C."
              "apellidos" => "BLASCO CABAÑAS"
            ]
            5 => array:2 [
              "Iniciales" => "D."
              "apellidos" => "MARQUINA PARRA"
            ]
            6 => array:2 [
              "Iniciales" => "C."
              "apellidos" => "GRAU PUEYO"
            ]
            7 => array:2 [
              "Iniciales" => "M."
              "apellidos" => "GARCÍA GARCÍA"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699511051574"
        "doi" => "10.3265/Nefrologia.pre2010.Nov.10508"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511051574?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411051571?idApp=UINPBA000064"
    "url" => "/20132514/0000003100000002/v0_201502091641/X2013251411051571/v0_201502091641/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251411051598"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.pre2010.Dec.10741"
    "estado" => "S300"
    "fechaPublicacion" => "2011-03-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2011;31:219-21"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 5118
      "formatos" => array:3 [
        "EPUB" => 298
        "HTML" => 4086
        "PDF" => 734
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Successful pregnancy in a patient with chronic renal failure undergoing haemodialysis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "219"
          "paginaFinal" => "221"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Gestación con éxito en una paciente con insuficiencia renal crónica en programa de hemodiálisis"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Tab.  1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier España"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "10741_108_15824_en_t2_carta.jpg"
              "Alto" => 349
              "Ancho" => 600
              "Tamanyo" => 155686
            ]
          ]
          "descripcion" => array:1 [
            "en" => "Clinical and laboratory variables and drug dose during pregnancy"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "K.R. Furaz Czerpak, A. Puente García, E. Corchete Prats, M.A. Moreno, R. Martín Hernandez"
          "autores" => array:5 [
            0 => array:2 [
              "Iniciales" => "K.R."
              "apellidos" => "Furaz Czerpak"
            ]
            1 => array:2 [
              "Iniciales" => "A."
              "apellidos" => "Puente García"
            ]
            2 => array:2 [
              "Iniciales" => "E."
              "apellidos" => "Corchete Prats"
            ]
            3 => array:2 [
              "Iniciales" => "M.A."
              "apellidos" => "Moreno"
            ]
            4 => array:2 [
              "Iniciales" => "R."
              "apellidos" => "Martín Hernandez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699511051590"
        "doi" => "10.3265/Nefrologia.pre2010.Dec.10741"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511051590?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411051598?idApp=UINPBA000064"
    "url" => "/20132514/0000003100000002/v0_201502091641/X2013251411051598/v0_201502091641/en/main.assets"
  ]
  "en" => array:10 [
    "idiomaDefecto" => true
    "titulo" => "Nephropathy following administration of angiogenesis inhibitors"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "221"
        "paginaFinal" => "222"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "ARANTXA VELLO ROMÁN, A. Vello Román, MIRIAM SAMPRÓN RODRÍGUEZ, M. Samprón Rodríguez, BEATRIZ PAZOS ARIAS, B. Pazos Arias, CARLOS ROMERO REINOSO, C. Romero Reinoso, ANGELES PETEIRO CANCELO, A. Peteiro Cancelo"
        "autores" => array:10 [
          0 => array:4 [
            "nombre" => "ARANTXA"
            "apellidos" => "VELLO ROMÁN"
            "email" => array:1 [
              0 => "arantxavr6@hotmail.com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:4 [
            "Iniciales" => "A."
            "apellidos" => "Vello Rom&#225;n"
            "email" => array:1 [
              0 => "arantxavr6&#64;hotmail&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "MIRIAM"
            "apellidos" => "SAMPR&#211;N RODR&#205;GUEZ"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          3 => array:3 [
            "Iniciales" => "M."
            "apellidos" => "Sampr&#243;n Rodr&#237;guez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "BEATRIZ"
            "apellidos" => "PAZOS ARIAS"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          5 => array:3 [
            "Iniciales" => "B."
            "apellidos" => "Pazos Arias"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "CARLOS"
            "apellidos" => "ROMERO REINOSO"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          7 => array:3 [
            "Iniciales" => "C."
            "apellidos" => "Romero Reinoso"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "affc"
              ]
            ]
          ]
          8 => array:3 [
            "nombre" => "ANGELES"
            "apellidos" => "PETEIRO CANCELO"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "affd"
              ]
            ]
          ]
          9 => array:3 [
            "Iniciales" => "A."
            "apellidos" => "Peteiro Cancelo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "affe"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:5 [
          0 => array:3 [
            "entidad" => "NEFROLOGIA, Hospital Povisa, Vigo, PONTEVEDRA, Spain, "
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
          1 => array:3 [
            "entidad" => "Servicio de Nefrología, Hospital Povisa, Vigo, Pontevedra,  "
            "etiqueta" => "<span class="elsevierStyleSup">b</span>"
            "identificador" => "affb"
          ]
          2 => array:3 [
            "entidad" => "Servicio de Oncología, Hospital Povisa, Vigo, Pontevedra,  "
            "etiqueta" => "<span class="elsevierStyleSup">c</span>"
            "identificador" => "affc"
          ]
          3 => array:3 [
            "entidad" => "ANATOMÍA PATOLÓGICA, Hospital Povisa, Vigo, PONTEVEDRA, Spain, "
            "etiqueta" => "<span class="elsevierStyleSup">d</span>"
            "identificador" => "affd"
          ]
          4 => array:3 [
            "entidad" => "Servicio de Anatomía Patológica, Hospital Povisa, Vigo, Pontevedra,  "
            "etiqueta" => "<span class="elsevierStyleSup">e</span>"
            "identificador" => "affe"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Nefropat&#237;a tras la administraci&#243;n de inhibidores de la angiog&#233;nesis"
      ]
    ]
    "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">To the Editor&#44; </span></p><p class="elsevierStylePara">Angiogenesis has an important role in metastasis development&#46; In recent years&#44; the vascular endothelial growth factor &#40;VEGF&#41; has become one of the main objectives in treating tumour-induced angiogenesis&#46;</p><p class="elsevierStylePara">Various studies have shown that the anti-VEGF monoclonal antibody&#44; bevacizumab&#44; can reduce angiogenesis and inhibit solid tumour growth&#46;<span class="elsevierStyleSup">1</span></p><p class="elsevierStylePara">Various secondary effects have been associated with bevacizumab use&#46; Two of the most common effects are moderate proteinuria &#40;up to 64&#37; of cases&#41; and hypertension&#46; Nephrotic-range proteinuria only occurs in 1&#37;-2&#37; of bevacizumab-treated patients&#46;<span class="elsevierStyleSup">2</span></p><p class="elsevierStylePara">We present the case of a 42-year-old man&#44; diagnosed with grade II fibrosarcoma in the thigh and left-scapular region in November 1999&#46; Tumour resection was indicated&#46;</p><p class="elsevierStylePara">Three years later&#44; he developed progressive pulmonary metastatic disease&#44; which was treated with surgery and chemotherapy &#40;MAID protocol&#58; mesna&#44; adriamycin&#44; ifosfamide and dacarbazine&#41;&#46;</p><p class="elsevierStylePara">In May 2004&#44; he developed progressive pulmonary metastatic disease again and was treated with taxotere and gemcitabine&#44; completing 6 cycles&#46; He then completed 21 cycles of therapy with gemcitabine only&#46;</p><p class="elsevierStylePara">In August 2008&#44; he started gemcitabine and bevacizumab treatment&#44; due to a disease relapse&#46;</p><p class="elsevierStylePara">Following the second bevacizumab dosage&#44; the patient was admitted due to headache&#44; arterial hypertension &#40;AHT&#41; &#40;BP&#58; 190&#47;100mm Hg&#41; and general oedema&#46; Upon admission&#44; he had creatinine at 1&#46;8mg&#47;dl&#44; nephrotic-range proteinuria and microhaematuria&#46; Moderate normocytic&#47;normochromic anaemia without schistocytes on the peripheral blood smear&#46; Kidney ultrasound was normal&#46; Immunological study only had low C3 levels&#46; He had no previous history of AHT or kidney disease&#46;</p><p class="elsevierStylePara">On the sixth day of his hospital stay&#44; a renal biopsy was performed finding mesangiocapillary glomerulonephritis type II&#46;</p><p class="elsevierStylePara">Gemcitabine and bevacizumab treatment was suspended and angiotensin II receptor antagonist &#40;ARA-II&#41; treatment started&#46; Renal function improved&#44; finally reaching creatinine levels of 1&#46;1mg&#47;dl&#59; proteinuria decreased significantly and optimum blood pressure control was achieved&#46;</p><p class="elsevierStylePara">Proteinuria in anti-VEGF-treated patients has been related to damage in the podocyte-endothelial-VEGF axis&#46; VEGF production by podocytes is necessary for the glomerular endothelial to remain intact&#46;<span class="elsevierStyleSup">2</span> VEGF is expressed in the podocytes and its receptors are found in the endothelial cells of the normal glomerular capillaries&#46;<span class="elsevierStyleSup">3 </span>When VEGF binds to its receptor&#44; it promotes an increase in the microvasculature&#8217;s permeability&#44; cell migration and division&#44; apoptosis inhibition and endothelial damage repair&#46;<span class="elsevierStyleSup">4 </span></p><p class="elsevierStylePara">In animal studies&#44; a defect in the VEGF expression causes glomerular diseases characterised by nephrotic-range proteinuria&#44; endotheliosis and hyaline deposits&#44; which are similar to the kidney damage found in pre-eclampsia patients&#46;<span class="elsevierStyleSup">5 </span></p><p class="elsevierStylePara">We only found a few glomerulonephritis cases associated with anti-VEGF antibodies in the medical literature&#44; and most were thrombotic microangiopathies&#46; Bevacizumab-induced mesangiocapillary glomerulonephritis seems to be very rare&#46; We believe that more cases will gradually appear due to the increased use of these antibodies in oncology in recent years&#46;</p><p class="elsevierStylePara">Proteinuria which appears as a result of bevacizumab-induced glomerular damage seems to be reversible&#44; at least partially&#44; when this chemotherapy agent is suspended&#46;</p><p class="elsevierStylePara">Our case&#44; and other similar cases of patients with metastasis which develop bevacizumab-induced proteinuria had been treated with other&#44; potentially nephrotoxic agents&#46; Our patient also received high doses of gemcitabine over a long period of time&#46; Little is still known about gemcitabine&#8217;s mechanism of action on kidney damage&#44; although we know that it is dose-dependent&#46; In most cases&#44; it is associated with haemolytic uremic syndrome&#44;<span class="elsevierStyleSup">6</span> although we have also found isolated cases associated with mesangiocapillary glomerulonephritis&#46;<span class="elsevierStyleSup">7 </span></p><p class="elsevierStylePara">Given that a kidney biopsy was not performed before bevacizumab treatment&#44; we are not able to confirm that gemcitabine was not responsible for the patient&#8217;s symptoms&#46; However&#44; given that the kidney damage was not evident until the start of anti-VEGF antibody treatment&#44; we believe that the agent responsible for these symptoms was bevacizumab&#46; It is possible that gemcitabine treatment produces initial renal damage&#44; which may have been exacerbated by bevacizumab administration&#46;</p><p class="elsevierStylePara">We recommend a strict control of the arterial pressure and kidney function in patients undergoing monoclonal antibody therapies&#46;</p>"
    "pdfFichero" => "P1-E518-S2912-A10729-EN.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "Bibliography"
      "seccion" => array:1 [
        0 => array:1 [
          "bibliografiaReferencia" => array:7 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "1.\u{A0}Rugo HS. Bevacizumab in the treatment of breast cancer: rationale and current data. The Oncologist 2004;9(Suppl 1):43-9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15178815" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008;358:1129-36. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18337603" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Stokes M, Erazo M, D¿Agati V. Glomerular disease related to anti-VEGF therapy. Kidney Int 2008;74:1487-91. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18547991" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis.\u{A0}Zhu X, Wu S, Dahut WL, Parikh CR. Am J Kidney Dis 2007;49:186-93. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17261421" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib5"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Nephrotic syndrome after bevacizumab: case report and literature review.\u{A0}George BA, Zhou XJ, Toto R. Am J Kidney Dis 2007;49:E23-E29. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17261417" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib6"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.\u{A0}Saif MW, McGee PJ. J Pancreas 2005;6(4):369-74."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib7"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma.\u{A0}Fracasso PM, Tan BR, Grieff JM, el al. Journal of the National Cancer Institute 1999;91(20):1779-80. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10528031" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000003100000002/v0_201502091641/X201325141105158X/v0_201502091641/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35437"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Letters to the Editor - Brief Case Reports"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003100000002/v0_201502091641/X201325141105158X/v0_201502091641/en/P1-E518-S2912-A10729-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325141105158X?idApp=UINPBA000064"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Nephropathy following administration of angiogenesis inhibitors
Nefropatía tras la administración de inhibidores de la angiogénesis
ARANTXA VELLO ROMÁNa, A.. Vello Románb, MIRIAM SAMPRÓN RODRÍGUEZa, M.. Samprón Rodríguezb, BEATRIZ PAZOS ARIASa, B.. Pazos Ariasb, CARLOS ROMERO REINOSOa, C.. Romero Reinosoc, ANGELES PETEIRO CANCELOd, A.. Peteiro Canceloe
a NEFROLOGIA, Hospital Povisa, Vigo, PONTEVEDRA, Spain,
b Servicio de Nefrología, Hospital Povisa, Vigo, Pontevedra,
c Servicio de Oncología, Hospital Povisa, Vigo, Pontevedra,
d ANATOMÍA PATOLÓGICA, Hospital Povisa, Vigo, PONTEVEDRA, Spain,
e Servicio de Anatomía Patológica, Hospital Povisa, Vigo, Pontevedra,
Read
7567
Times
was read the article
2163
Total PDF
5404
Total HTML
Share statistics
 array:21 [
  "pii" => "X201325141105158X"
  "issn" => "20132514"
  "doi" => "10.3265/Nefrologia.pre2010.Nov.10729"
  "estado" => "S300"
  "fechaPublicacion" => "2011-03-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia &#40;English Version&#41;. 2011;31:221-2"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 4361
    "formatos" => array:3 [
      "EPUB" => 318
      "HTML" => 3498
      "PDF" => 545
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:17 [
      "pii" => "X0211699511051582"
      "issn" => "02116995"
      "doi" => "10.3265/Nefrologia.pre2010.Nov.10729"
      "estado" => "S300"
      "fechaPublicacion" => "2011-03-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2011;31:221-2"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 7071
        "formatos" => array:3 [
          "EPUB" => 318
          "HTML" => 6109
          "PDF" => 644
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "titulo" => "Nefropat&#237;a tras la administraci&#243;n de inhibidores de la angiog&#233;nesis"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "221"
            "paginaFinal" => "222"
          ]
        ]
        "contieneResumen" => array:1 [
          "es" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "ARANTXA VELLO ROM&#193;N, A. Vello Rom&#225;n, MIRIAM SAMPR&#211;N RODR&#205;GUEZ, M. Sampr&#243;n Rodr&#237;guez, BEATRIZ PAZOS ARIAS, B. Pazos Arias, CARLOS ROMERO REINOSO, C. Romero Reinoso, ANGELES PETEIRO CANCELO, A. Peteiro Cancelo"
            "autores" => array:10 [
              0 => array:2 [
                "nombre" => "ARANTXA"
                "apellidos" => "VELLO ROM&#193;N"
              ]
              1 => array:2 [
                "Iniciales" => "A."
                "apellidos" => "Vello Rom&#225;n"
              ]
              2 => array:2 [
                "nombre" => "MIRIAM"
                "apellidos" => "SAMPR&#211;N RODR&#205;GUEZ"
              ]
              3 => array:2 [
                "Iniciales" => "M."
                "apellidos" => "Sampr&#243;n Rodr&#237;guez"
              ]
              4 => array:2 [
                "nombre" => "BEATRIZ"
                "apellidos" => "PAZOS ARIAS"
              ]
              5 => array:2 [
                "Iniciales" => "B."
                "apellidos" => "Pazos Arias"
              ]
              6 => array:2 [
                "nombre" => "CARLOS"
                "apellidos" => "ROMERO REINOSO"
              ]
              7 => array:2 [
                "Iniciales" => "C."
                "apellidos" => "Romero Reinoso"
              ]
              8 => array:2 [
                "nombre" => "ANGELES"
                "apellidos" => "PETEIRO CANCELO"
              ]
              9 => array:2 [
                "Iniciales" => "A."
                "apellidos" => "Peteiro Cancelo"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "X201325141105158X"
          "doi" => "10.3265/Nefrologia.pre2010.Nov.10729"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325141105158X?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511051582?idApp=UINPBA000064"
      "url" => "/02116995/0000003100000002/v0_201502091417/X0211699511051582/v0_201502091417/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251411051571"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.pre2010.Nov.10508"
    "estado" => "S300"
    "fechaPublicacion" => "2011-03-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2011;31:223-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 8435
      "formatos" => array:3 [
        "EPUB" => 314
        "HTML" => 7465
        "PDF" => 656
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "First case of peritoneal infection due to Oerskovia turbata &#40;Cellulosimicrobium funkei&#41;"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "223"
          "paginaFinal" => "225"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Primer caso de infecci&#243;n peritoneal por Oerskovia turbata &#40;Cellulosimicrobium funkei&#41;"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Fig. 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier Espa&#241;a"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "10508_108_15826_en_10508_1.jpg"
              "Alto" => 399
              "Ancho" => 600
              "Tamanyo" => 191528
            ]
          ]
          "descripcion" => array:1 [
            "en" => "Oerskovia culture on a blood agar plate"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L. BETANCOURT CASTELLANOS, E. PONZ CLEMENTE, D. FONTANALS AYMERICH, C. BLASCO CABA&#209;AS, D. MARQUINA PARRA, C. GRAU PUEYO, M. GARC&#205;A GARC&#205;A"
          "autores" => array:8 [
            0 => array:2 [
              "Iniciales" => "L."
              "apellidos" => "BETANCOURT CASTELLANOS"
            ]
            1 => array:2 [
              "Iniciales" => "L."
              "apellidos" => "BETANCOURT CASTELLANOS"
            ]
            2 => array:2 [
              "Iniciales" => "E."
              "apellidos" => "PONZ CLEMENTE"
            ]
            3 => array:2 [
              "Iniciales" => "D."
              "apellidos" => "FONTANALS AYMERICH"
            ]
            4 => array:2 [
              "Iniciales" => "C."
              "apellidos" => "BLASCO CABA&#209;AS"
            ]
            5 => array:2 [
              "Iniciales" => "D."
              "apellidos" => "MARQUINA PARRA"
            ]
            6 => array:2 [
              "Iniciales" => "C."
              "apellidos" => "GRAU PUEYO"
            ]
            7 => array:2 [
              "Iniciales" => "M."
              "apellidos" => "GARC&#205;A GARC&#205;A"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699511051574"
        "doi" => "10.3265/Nefrologia.pre2010.Nov.10508"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511051574?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411051571?idApp=UINPBA000064"
    "url" => "/20132514/0000003100000002/v0_201502091641/X2013251411051571/v0_201502091641/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251411051598"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.pre2010.Dec.10741"
    "estado" => "S300"
    "fechaPublicacion" => "2011-03-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2011;31:219-21"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 5118
      "formatos" => array:3 [
        "EPUB" => 298
        "HTML" => 4086
        "PDF" => 734
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Successful pregnancy in a patient with chronic renal failure undergoing haemodialysis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "219"
          "paginaFinal" => "221"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Gestaci&#243;n con &#233;xito en una paciente con insuficiencia renal cr&#243;nica en programa de hemodi&#225;lisis"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Tab.  1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier Espa&#241;a"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "10741_108_15824_en_t2_carta.jpg"
              "Alto" => 349
              "Ancho" => 600
              "Tamanyo" => 155686
            ]
          ]
          "descripcion" => array:1 [
            "en" => "Clinical and laboratory variables and drug dose during pregnancy"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "K.R. Furaz Czerpak, A. Puente Garc&#237;a, E. Corchete Prats, M.A. Moreno, R. Mart&#237;n Hernandez"
          "autores" => array:5 [
            0 => array:2 [
              "Iniciales" => "K.R."
              "apellidos" => "Furaz Czerpak"
            ]
            1 => array:2 [
              "Iniciales" => "A."
              "apellidos" => "Puente Garc&#237;a"
            ]
            2 => array:2 [
              "Iniciales" => "E."
              "apellidos" => "Corchete Prats"
            ]
            3 => array:2 [
              "Iniciales" => "M.A."
              "apellidos" => "Moreno"
            ]
            4 => array:2 [
              "Iniciales" => "R."
              "apellidos" => "Mart&#237;n Hernandez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699511051590"
        "doi" => "10.3265/Nefrologia.pre2010.Dec.10741"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511051590?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411051598?idApp=UINPBA000064"
    "url" => "/20132514/0000003100000002/v0_201502091641/X2013251411051598/v0_201502091641/en/main.assets"
  ]
  "en" => array:10 [
    "idiomaDefecto" => true
    "titulo" => "Nephropathy following administration of angiogenesis inhibitors"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "221"
        "paginaFinal" => "222"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "ARANTXA VELLO ROM&#193;N, A. Vello Rom&#225;n, MIRIAM SAMPR&#211;N RODR&#205;GUEZ, M. Sampr&#243;n Rodr&#237;guez, BEATRIZ PAZOS ARIAS, B. Pazos Arias, CARLOS ROMERO REINOSO, C. Romero Reinoso, ANGELES PETEIRO CANCELO, A. Peteiro Cancelo"
        "autores" => array:10 [
          0 => array:4 [
            "nombre" => "ARANTXA"
            "apellidos" => "VELLO ROM&#193;N"
            "email" => array:1 [
              0 => "arantxavr6&#64;hotmail&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:4 [
            "Iniciales" => "A."
            "apellidos" => "Vello Rom&#225;n"
            "email" => array:1 [
              0 => "arantxavr6&#64;hotmail&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "MIRIAM"
            "apellidos" => "SAMPR&#211;N RODR&#205;GUEZ"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          3 => array:3 [
            "Iniciales" => "M."
            "apellidos" => "Sampr&#243;n Rodr&#237;guez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "BEATRIZ"
            "apellidos" => "PAZOS ARIAS"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          5 => array:3 [
            "Iniciales" => "B."
            "apellidos" => "Pazos Arias"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "CARLOS"
            "apellidos" => "ROMERO REINOSO"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          7 => array:3 [
            "Iniciales" => "C."
            "apellidos" => "Romero Reinoso"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "affc"
              ]
            ]
          ]
          8 => array:3 [
            "nombre" => "ANGELES"
            "apellidos" => "PETEIRO CANCELO"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "affd"
              ]
            ]
          ]
          9 => array:3 [
            "Iniciales" => "A."
            "apellidos" => "Peteiro Cancelo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "affe"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:5 [
          0 => array:3 [
            "entidad" => "NEFROLOGIA, Hospital Povisa, Vigo, PONTEVEDRA, Spain, "
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
          1 => array:3 [
            "entidad" => "Servicio de Nefrología, Hospital Povisa, Vigo, Pontevedra,  "
            "etiqueta" => "<span class="elsevierStyleSup">b</span>"
            "identificador" => "affb"
          ]
          2 => array:3 [
            "entidad" => "Servicio de Oncología, Hospital Povisa, Vigo, Pontevedra,  "
            "etiqueta" => "<span class="elsevierStyleSup">c</span>"
            "identificador" => "affc"
          ]
          3 => array:3 [
            "entidad" => "ANATOMÍA PATOLÓGICA, Hospital Povisa, Vigo, PONTEVEDRA, Spain, "
            "etiqueta" => "<span class="elsevierStyleSup">d</span>"
            "identificador" => "affd"
          ]
          4 => array:3 [
            "entidad" => "Servicio de Anatomía Patológica, Hospital Povisa, Vigo, Pontevedra,  "
            "etiqueta" => "<span class="elsevierStyleSup">e</span>"
            "identificador" => "affe"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Nefropat&#237;a tras la administraci&#243;n de inhibidores de la angiog&#233;nesis"
      ]
    ]
    "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">To the Editor&#44; </span></p><p class="elsevierStylePara">Angiogenesis has an important role in metastasis development&#46; In recent years&#44; the vascular endothelial growth factor &#40;VEGF&#41; has become one of the main objectives in treating tumour-induced angiogenesis&#46;</p><p class="elsevierStylePara">Various studies have shown that the anti-VEGF monoclonal antibody&#44; bevacizumab&#44; can reduce angiogenesis and inhibit solid tumour growth&#46;<span class="elsevierStyleSup">1</span></p><p class="elsevierStylePara">Various secondary effects have been associated with bevacizumab use&#46; Two of the most common effects are moderate proteinuria &#40;up to 64&#37; of cases&#41; and hypertension&#46; Nephrotic-range proteinuria only occurs in 1&#37;-2&#37; of bevacizumab-treated patients&#46;<span class="elsevierStyleSup">2</span></p><p class="elsevierStylePara">We present the case of a 42-year-old man&#44; diagnosed with grade II fibrosarcoma in the thigh and left-scapular region in November 1999&#46; Tumour resection was indicated&#46;</p><p class="elsevierStylePara">Three years later&#44; he developed progressive pulmonary metastatic disease&#44; which was treated with surgery and chemotherapy &#40;MAID protocol&#58; mesna&#44; adriamycin&#44; ifosfamide and dacarbazine&#41;&#46;</p><p class="elsevierStylePara">In May 2004&#44; he developed progressive pulmonary metastatic disease again and was treated with taxotere and gemcitabine&#44; completing 6 cycles&#46; He then completed 21 cycles of therapy with gemcitabine only&#46;</p><p class="elsevierStylePara">In August 2008&#44; he started gemcitabine and bevacizumab treatment&#44; due to a disease relapse&#46;</p><p class="elsevierStylePara">Following the second bevacizumab dosage&#44; the patient was admitted due to headache&#44; arterial hypertension &#40;AHT&#41; &#40;BP&#58; 190&#47;100mm Hg&#41; and general oedema&#46; Upon admission&#44; he had creatinine at 1&#46;8mg&#47;dl&#44; nephrotic-range proteinuria and microhaematuria&#46; Moderate normocytic&#47;normochromic anaemia without schistocytes on the peripheral blood smear&#46; Kidney ultrasound was normal&#46; Immunological study only had low C3 levels&#46; He had no previous history of AHT or kidney disease&#46;</p><p class="elsevierStylePara">On the sixth day of his hospital stay&#44; a renal biopsy was performed finding mesangiocapillary glomerulonephritis type II&#46;</p><p class="elsevierStylePara">Gemcitabine and bevacizumab treatment was suspended and angiotensin II receptor antagonist &#40;ARA-II&#41; treatment started&#46; Renal function improved&#44; finally reaching creatinine levels of 1&#46;1mg&#47;dl&#59; proteinuria decreased significantly and optimum blood pressure control was achieved&#46;</p><p class="elsevierStylePara">Proteinuria in anti-VEGF-treated patients has been related to damage in the podocyte-endothelial-VEGF axis&#46; VEGF production by podocytes is necessary for the glomerular endothelial to remain intact&#46;<span class="elsevierStyleSup">2</span> VEGF is expressed in the podocytes and its receptors are found in the endothelial cells of the normal glomerular capillaries&#46;<span class="elsevierStyleSup">3 </span>When VEGF binds to its receptor&#44; it promotes an increase in the microvasculature&#8217;s permeability&#44; cell migration and division&#44; apoptosis inhibition and endothelial damage repair&#46;<span class="elsevierStyleSup">4 </span></p><p class="elsevierStylePara">In animal studies&#44; a defect in the VEGF expression causes glomerular diseases characterised by nephrotic-range proteinuria&#44; endotheliosis and hyaline deposits&#44; which are similar to the kidney damage found in pre-eclampsia patients&#46;<span class="elsevierStyleSup">5 </span></p><p class="elsevierStylePara">We only found a few glomerulonephritis cases associated with anti-VEGF antibodies in the medical literature&#44; and most were thrombotic microangiopathies&#46; Bevacizumab-induced mesangiocapillary glomerulonephritis seems to be very rare&#46; We believe that more cases will gradually appear due to the increased use of these antibodies in oncology in recent years&#46;</p><p class="elsevierStylePara">Proteinuria which appears as a result of bevacizumab-induced glomerular damage seems to be reversible&#44; at least partially&#44; when this chemotherapy agent is suspended&#46;</p><p class="elsevierStylePara">Our case&#44; and other similar cases of patients with metastasis which develop bevacizumab-induced proteinuria had been treated with other&#44; potentially nephrotoxic agents&#46; Our patient also received high doses of gemcitabine over a long period of time&#46; Little is still known about gemcitabine&#8217;s mechanism of action on kidney damage&#44; although we know that it is dose-dependent&#46; In most cases&#44; it is associated with haemolytic uremic syndrome&#44;<span class="elsevierStyleSup">6</span> although we have also found isolated cases associated with mesangiocapillary glomerulonephritis&#46;<span class="elsevierStyleSup">7 </span></p><p class="elsevierStylePara">Given that a kidney biopsy was not performed before bevacizumab treatment&#44; we are not able to confirm that gemcitabine was not responsible for the patient&#8217;s symptoms&#46; However&#44; given that the kidney damage was not evident until the start of anti-VEGF antibody treatment&#44; we believe that the agent responsible for these symptoms was bevacizumab&#46; It is possible that gemcitabine treatment produces initial renal damage&#44; which may have been exacerbated by bevacizumab administration&#46;</p><p class="elsevierStylePara">We recommend a strict control of the arterial pressure and kidney function in patients undergoing monoclonal antibody therapies&#46;</p>"
    "pdfFichero" => "P1-E518-S2912-A10729-EN.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "Bibliography"
      "seccion" => array:1 [
        0 => array:1 [
          "bibliografiaReferencia" => array:7 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "1.\u{A0}Rugo HS. Bevacizumab in the treatment of breast cancer: rationale and current data. The Oncologist 2004;9(Suppl 1):43-9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15178815" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008;358:1129-36. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18337603" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Stokes M, Erazo M, D¿Agati V. Glomerular disease related to anti-VEGF therapy. Kidney Int 2008;74:1487-91. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18547991" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis.\u{A0}Zhu X, Wu S, Dahut WL, Parikh CR. Am J Kidney Dis 2007;49:186-93. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17261421" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib5"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Nephrotic syndrome after bevacizumab: case report and literature review.\u{A0}George BA, Zhou XJ, Toto R. Am J Kidney Dis 2007;49:E23-E29. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17261417" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib6"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.\u{A0}Saif MW, McGee PJ. J Pancreas 2005;6(4):369-74."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib7"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma.\u{A0}Fracasso PM, Tan BR, Grieff JM, el al. Journal of the National Cancer Institute 1999;91(20):1779-80. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10528031" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000003100000002/v0_201502091641/X201325141105158X/v0_201502091641/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35437"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Letters to the Editor - Brief Case Reports"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003100000002/v0_201502091641/X201325141105158X/v0_201502091641/en/P1-E518-S2912-A10729-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325141105158X?idApp=UINPBA000064"
]
Article information
ISSN: 20132514
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 3 2 5
2024 October 53 42 95
2024 September 46 36 82
2024 August 55 58 113
2024 July 39 25 64
2024 June 40 43 83
2024 May 48 24 72
2024 April 38 37 75
2024 March 30 23 53
2024 February 164 37 201
2024 January 26 24 50
2023 December 18 17 35
2023 November 26 28 54
2023 October 23 30 53
2023 September 30 32 62
2023 August 32 23 55
2023 July 31 28 59
2023 June 30 24 54
2023 May 43 33 76
2023 April 18 10 28
2023 March 32 26 58
2023 February 19 31 50
2023 January 31 22 53
2022 December 39 22 61
2022 November 30 39 69
2022 October 40 47 87
2022 September 41 45 86
2022 August 43 54 97
2022 July 30 48 78
2022 June 34 27 61
2022 May 31 40 71
2022 April 38 52 90
2022 March 35 29 64
2022 February 30 33 63
2022 January 42 30 72
2021 December 29 36 65
2021 November 33 42 75
2021 October 32 46 78
2021 September 30 45 75
2021 August 25 37 62
2021 July 27 28 55
2021 June 19 22 41
2021 May 34 37 71
2021 April 69 16 85
2021 March 36 41 77
2021 February 24 8 32
2021 January 20 17 37
2020 December 20 18 38
2020 November 24 7 31
2020 October 11 18 29
2020 September 15 5 20
2020 August 21 9 30
2020 July 28 8 36
2020 June 19 11 30
2020 May 20 12 32
2020 April 23 18 41
2020 March 21 8 29
2020 February 29 28 57
2020 January 28 18 46
2019 December 31 22 53
2019 November 30 17 47
2019 October 13 9 22
2019 September 28 15 43
2019 August 10 11 21
2019 July 18 20 38
2019 June 15 6 21
2019 May 12 10 22
2019 April 24 32 56
2019 March 15 17 32
2019 February 11 17 28
2019 January 22 14 36
2018 December 92 49 141
2018 November 155 23 178
2018 October 171 22 193
2018 September 80 5 85
2018 August 67 13 80
2018 July 43 9 52
2018 June 41 9 50
2018 May 42 11 53
2018 April 47 4 51
2018 March 71 8 79
2018 February 37 4 41
2018 January 47 6 53
2017 December 50 8 58
2017 November 42 5 47
2017 October 35 10 45
2017 September 63 10 73
2017 August 44 3 47
2017 July 53 10 63
2017 June 43 4 47
2017 May 56 10 66
2017 April 52 5 57
2017 March 40 22 62
2017 February 22 10 32
2017 January 31 7 38
2016 December 67 11 78
2016 November 75 9 84
2016 October 68 17 85
2016 September 131 3 134
2016 August 194 4 198
2016 July 173 6 179
2016 June 123 0 123
2016 May 120 0 120
2016 April 76 0 76
2016 March 79 0 79
2016 February 92 0 92
2016 January 103 0 103
2015 December 106 0 106
2015 November 68 0 68
2015 October 60 0 60
2015 September 68 0 68
2015 August 55 0 55
2015 July 53 0 53
2015 June 38 0 38
2015 May 50 0 50
2015 April 7 0 7
Show all

Follow this link to access the full text of the article

Idiomas
Nefrología (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?